Correlation Between Qualigen Therapeutics and Blue Whale

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Blue Whale at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Blue Whale into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Blue Whale Acquisition, you can compare the effects of market volatilities on Qualigen Therapeutics and Blue Whale and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Blue Whale. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Blue Whale.

Diversification Opportunities for Qualigen Therapeutics and Blue Whale

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Qualigen and Blue is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Blue Whale Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blue Whale Acquisition and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Blue Whale. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blue Whale Acquisition has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Blue Whale go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Blue Whale

If you would invest  1,011  in Blue Whale Acquisition on August 30, 2024 and sell it today you would earn a total of  0.00  from holding Blue Whale Acquisition or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy4.55%
ValuesDaily Returns

Qualigen Therapeutics  vs.  Blue Whale Acquisition

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Blue Whale Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Blue Whale Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Blue Whale is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Qualigen Therapeutics and Blue Whale Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and Blue Whale

The main advantage of trading using opposite Qualigen Therapeutics and Blue Whale positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Blue Whale can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blue Whale will offset losses from the drop in Blue Whale's long position.
The idea behind Qualigen Therapeutics and Blue Whale Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets